bioAffinity advances CyPath Lung test for lung cancer survivor surveillance
bioAffinity Technologies said it is advancing the potential application of its CyPath Lung test for surveillance of lung cancer survivors.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.